Retraction: The cellular source for APOBEC3G's incorporation into HIV-1 [Retrovirology, 8, (2011) (2)] DOI:10.1186/1742-4690-8-2;The cellular source for APOBEC3G's incorporation into HIV-1

Retrovirology

Volumn 8, Issue , 2011, Pages

  Ma, Jing ^a,c,d   Li, Xiaoyu ^a   Xu, Jian ^a   Zhang, Quan ^a   Liu, Zhenlong ^a   Jia, Pingping ^a   Zhou, Jinming ^a   Guo, Fei ^b   You, Xuefu ^a   Yu, Liyan ^a   Zhao, Lixun ^a   Jiang, Jiandong ^a   Cen, Shan ^a,c,d  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; MUTANT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; MOLECULAR WEIGHT; MUTAGENESIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN SYNTHESIS; STEADY STATE; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; GENETICS; METABOLISM; PHYSIOLOGY; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CYTIDINE DEAMINASE; HIV-1; HUMANS; MUTAGENESIS; MUTANT PROTEINS; VIRUS ASSEMBLY;

EID: 78650880825     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-88     Document Type: Erratum

References (35)

1. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650. 10.1038/nature00939, 12167863.
2. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79:285-296. 10.1006/geno.2002.6718, 11863358.
3. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060. 10.1126/science.1089591, 14564014.
4. Stopak K, de Noronha C, Yonemoto W, Greene WC. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 2003, 12:591-601. 10.1016/S1097-2765(03)00353-8, 14527406.
5. Alce TM, Popik W. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein. J Biol Chem 2004, 279:34083-34086. 10.1074/jbc.C400235200, 15215254.
6. Cen S, Guo F, Niu M, Saadatmand J, Deflassieux J, Kleiman L. The interaction between HIV-1 Gag and APOBEC3G. J Biol Chem 2004, 279:33177-33184. 10.1074/jbc.M402062200, 15159405.
7. Khan MA, Kao S, Miyagi E, Takeuchi H, Goila-Gaur R, Opi S, Gipson CL, Parslow TG, Ly H, Strebel K. Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J Virol 2005, 79:5870-5874. 10.1128/JVI.79.9.5870-5874.2005, 1082784, 15827203.
8. Schafer A, Bogerd HP, Cullen BR. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology 2004, 328:163-168. 10.1016/j.virol.2004.08.006, 15464836.
9. Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol 2004, 78:12058-12061. 10.1128/JVI.78.21.12058-12061.2004, 523273, 15479846.
10. Strebel K, Khan MA. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?. Retrovirology 2008, 5:55. 10.1186/1742-4690-5-55, 2491656, 18597677.
11. Friew YN, Boyko V, Hu WS, Pathak VK. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA. Retrovirology 2009, 6:56. 10.1186/1742-4690-6-56, 2700067, 19497112.
12. Bach D, Peddi S, Mangeat B, Lakkaraju A, Strub K, Trono D. Characterization of APOBEC3G binding to 7SL RNA. Retrovirology 2008, 5:54. 10.1186/1742-4690-5-54, 2494554, 18597676.
13. Chiu YL, Greene WC. APOBEC3G: an intracellular centurion. Philos Trans R Soc Lond B Biol Sci 2009, 364:689-703. 10.1098/rstb.2008.0193, 2660915, 19008196.
14. Gallois-Montbrun S, Holmes RK, Swanson CM, Fernandez-Ocana M, Byers HL, Ward MA, Malim MH. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol 2008, 82:5636-5642. 10.1128/JVI.00287-08, 2395208, 18367521.
15. Wang T, Tian C, Zhang W, Luo K, Sarkis PT, Yu L, Liu B, Yu Y, Yu XF. 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G. J Virol 2007, 81:13112-13124. 10.1128/JVI.00892-07, 2169093, 17881443.
16. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 2006, 281:29105-29119. 10.1074/jbc.M601901200, 16887808.
17. Soros VB, Yonemoto W, Greene WC. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog 2007, 3:e15. 10.1371/journal.ppat.0030015, 1796622, 17291161.
18. Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC, Strebel K. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization. Retrovirology 2009, 6:99. 10.1186/1742-4690-6-99, 2776001, 19886996.
19. Wang X, Dolan PT, Dang Y, Zheng YH. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle. J Biol Chem 2007, 282:1585-1594. 10.1074/jbc.M610150200, 1880894, 17142455.
20. Yu J, Fischman DA, Steck TL. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct 1973, 1:233-248. 10.1002/jss.400010308, 4804838.
21. Halwani R, Khorchid A, Cen S, Kleiman L. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of HIV-1. J Virol 2003, 77:3973-3984. 10.1128/JVI.77.7.3973-3984.2003, 150626, 12634357.
22. Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003, 9:1398-1403. 10.1038/nm946, 14528301.
23. Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003, 9:1404-1407. 10.1038/nm945, 14528300.
24. Huthoff H, Malim MH. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation. J Virol 2007, 81:3807-3815. 10.1128/JVI.02795-06, 1866099, 17267497.
25. Zhang KL, Mangeat B, Ortiz M, Zoete V, Trono D, Telenti A, Michielin O. Model structure of human APOBEC3G. PLoS One 2007, 2:e378. 10.1371/journal.pone.0000378, 1849894, 17440614.
26. Kreisberg JF, Yonemoto W, Greene WC. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med 2006, 203:865-870. 10.1084/jem.20051856, 2118295, 16606671.
27. Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 2007, 282:3539-3546. 10.1074/jbc.M610138200, 17110377.
28. Bennett RP, Presnyak V, Wedekind JE, Smith HC. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding. J Biol Chem 2008, 283:7320-7327. 10.1074/jbc.M708567200, 18165230.
29. Conticello SG, Harris RS, Neuberger MS. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 2003, 13:2009-2013. 10.1016/j.cub.2003.10.034, 14614829.
30. Huang Y, Kong W-P, Nabel GJ. Human immunodeficiency virus type I-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol 2001, 75:4947-4951. 10.1128/JVI.75.10.4947-4951.2001, 114253, 11312370.
31. Guo F, Cen S, Niu M, Saadatmand J, Kleiman L. The inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during HIV-1 replication. J Virol 2006, 80:11710-11722. 10.1128/JVI.01038-06, 1642613, 16971427.
32. Roy BB, Hu J, Guo X, Russell RS, Guo F, Kleiman L, Liang C. Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem 2006, 281:12625-12635. 10.1074/jbc.M510596200, 16527808.
33. Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol 2000, 74:5441-5451. 10.1128/JVI.74.12.5441-5451.2000, 112028, 10823848.
34. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA 2001, 98:13925-13930. 10.1073/pnas.241320298, 61143, 11717449.
35. Khorchid A, Halwani R, Wainberg MA, Kleiman L. Role of RNA in facilitating Gag/Gag-Pol Interaction. J Virol 2002, 76:4131-4137. 10.1128/JVI.76.8.4131-4137.2002, 136082, 11907255.